Group1
Group1 is a behavioral intervention with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX-2
Lower Extremity Evaluation in Children With Diparetic Cerebral Palsy According to ICF Perspective
Effects of Peas on Blood Glucose Control
Real-time Identification of the Aberrant Left Hepatic Arterial Territory in the Liver Using Near-infrared Fluorescence Imaging
The Effect of the Covid 19 Pandemic Process on the Neuromotor Developments of 6-24 Month-old Babies
Clinical Trials (9)
Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX-2
Lower Extremity Evaluation in Children With Diparetic Cerebral Palsy According to ICF Perspective
Effects of Peas on Blood Glucose Control
Real-time Identification of the Aberrant Left Hepatic Arterial Territory in the Liver Using Near-infrared Fluorescence Imaging
The Effect of the Covid 19 Pandemic Process on the Neuromotor Developments of 6-24 Month-old Babies
Uqora Supplements in Women With UTIs
The Children's WEAR Trial(Phase 1&2)
Senior-COVID-Rea Multicentric Survey
Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients
All 9 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 9